191.032 articles found

Clinical implications and electrochemical biosensing of monoamine neurotransmitters in body fluids, in vitro, in vivo, and ex vivo models.

Baranwal A, Chandra P.

Biosens Bioelectron · 2018-09-03

DOI: 10.1016/j.bios.2018.09.002PMID: 30212666

In vitro neurotoxicity of salsolinol is attenuated by the presynaptic protein α-synuclein.

do Carmo-Gonçalves P, Coelho-Cerqueira E, Cortines JR, de Souza TLF, Romão L, Follmer C.

Biochim Biophys Acta Gen Subj · 2018-09-03

DOI: 10.1016/j.bbagen.2018.08.022PMID: 30251672

Antipsychotic Drug Dispensing in Older Adults With Parkinsonism.

Marras C, Austin PC, Bronskill SE, Diong C, Rochon PA.

Am J Geriatr Psychiatry · 2018-09-03

DOI: 10.1016/j.jagp.2018.08.003PMID: 30262407

Cognitive disorders in normal pressure hydrocephalus with initial parkinsonism in comparison with de novo Parkinson's disease.

Picascia M, Pozzi NG, Todisco M, Minafra B, Sinforiani E, Zangaglia R, Ceravolo R, Pacchetti C.

Eur J Neurol · 2018-09-03

DOI: 10.1111/ene.13766PMID: 30091839

Parkinson's Disease Diagnosis via Joint Learning From Multiple Modalities and Relations.

Lei H, Huang Z, Zhou F, Elazab A, Tan EL, Li H, Qin J, Lei B.

IEEE J Biomed Health Inform · 2018-09-03

DOI: 10.1109/jbhi.2018.2868420PMID: 30183649

Pedunculopontine nucleus: An integrative view with implications on Deep Brain Stimulation.

Nowacki A, Galati S, Ai-Schlaeppi J, Bassetti C, Kaelin A, Pollo C.

Neurobiol Dis · 2018-09-03

DOI: 10.1016/j.nbd.2018.08.015PMID: 30189263

The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson's Disease.

Weng M, Xie X, Liu C, Lim KL, Zhang CW, Li L.

Parkinsons Dis · 2018-09-02

DOI: 10.1155/2018/9163040PMID: 30245802

AB060. The effect of buspirone on refractory neurogenic retrograde ejaculation to pseudoephedrine

Check source for author details

Translational andrology and urology · 2018-09-01

Yield and Accumulation Trend of Biomass and L‐DOPA in Different Parts of Eight Faba Bean Cultivars

Etemadi F, Hāshimī Rakāvandī M, Autio WR, Mangan FX, Zandvakili O.

Crop Science. · 2018-09-01

DOI: 10.2135/cropsci2018.03.0172

Clinical Review Report: Levodopa/Carbidopa (Duodopa): (Abbvie Corporation): Indication: For the treatment of patients with advanced levodopa-responsive Parkinson’s disease who do not have satisfactory control of severe, debilitating motor fluctuations and hyper-/dyskinesia despite optimized treatment with available combinations of Parkinson’s medicinal products, and, for whom the benefits of this treatment may outweigh the risks associated with the insertion and long-term use of the percutaneous endoscopic gastrostomy-jejunostomy (PEG-J) tube required for administration

Check source for author details

· 2018-09-01

PMID: 30958666

Pharmacoeconomic Review Report: Levodopa/Carbidopa (Duodopa): (Abbvie Corporation): Indication: For the treatment of patients with advanced levodopa-responsive Parkinson’s disease who do not have satisfactory control of severe, debilitating motor fluctuations and hyper-/dyskinesia despite optimized treatment with available combinations of Parkinson’s medicinal products, and, for whom the benefits of this treatment may outweigh the risks associated with the insertion and long-term use of the percutaneous endoscopic gastrostomy-jejunostomy (PEG-J) tube required for administration

Check source for author details

· 2018-09-01

PMID: 30942993

The Case of Total Parenteral Nutrition Precipitated Neuroleptic Malignant-Like Syndrome in Advanced Stage Parkinson Disease.

Li W, Saweris M, Madhira B.

Am J Ther · 2018-09-01

DOI: 10.1097/mjt.0000000000000623PMID: 28731860